glp 1 for obesity GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron Weight Loss and Medical Weight Loss Solutions |
Description
Indeed, studies on the use of GLP-1Ra mostly included patients with diabetes who were administered a dose used in this condition, did not have adequate bone parameters as primary endpoints, and had short follow-up periods
Reduces body fat*^
The key takeaway
The treatment landscape for childhood obesity is evolving with the introduction of glucagon-like peptide-1 (GLP-1) receptor agonists in pediatrics
Helps to improve supplement stability, increase efficacy
No real change
